Central VetPharma Consultancy ApS — Credit Rating and Financial Key Figures
CVR number: 38773984
Suserupvej 34, 4180 Sorø
info@centralvetpharma.com
tel: 22946600
www.centralvetpharma.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 1 540.54 | 1 292.92 | 1 407.21 | 1 359.51 | 1 279.64 |
Employee benefit expenses | - 634.31 | - 910.88 | - 799.37 | - 720.89 | -1 031.33 |
Total depreciation | -5.00 | -5.00 | -5.00 | -5.00 | -5.00 |
EBIT | 901.23 | 377.05 | 602.84 | 633.63 | 243.31 |
Other financial income | 434.74 | 366.78 | -42.15 | 403.61 | 379.42 |
Other financial expenses | -16.71 | -0.20 | - 683.05 | -0.71 | -5.28 |
Pre-tax profit | 1 319.25 | 743.63 | - 122.36 | 1 036.52 | 617.45 |
Income taxes | - 292.58 | - 178.19 | 25.20 | - 232.90 | - 138.34 |
Net earnings | 1 026.68 | 565.43 | -97.17 | 803.63 | 479.12 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Goodwill | 30.00 | 25.00 | 20.00 | 15.00 | 10.00 |
Intangible assets total | 30.00 | 25.00 | 20.00 | 15.00 | 10.00 |
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 318.41 | 257.70 | 115.58 | 142.68 | 162.97 |
Current other receivables | 3.20 | ||||
Current deferred tax assets | 6.43 | 146.56 | 7.26 | 22.02 | |
Short term receivables total | 318.41 | 264.13 | 265.34 | 149.94 | 184.99 |
Other current investments | 3 112.29 | 3 571.48 | 3 093.30 | 3 712.48 | 4 058.20 |
Cash and bank deposits | 86.53 | 88.62 | 332.51 | 565.26 | 266.75 |
Cash and cash equivalents | 3 198.82 | 3 660.10 | 3 425.82 | 4 277.74 | 4 324.95 |
Balance sheet total (assets) | 3 547.23 | 3 949.22 | 3 711.16 | 4 442.68 | 4 519.94 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Shares repurchased | 113.00 | -2.91 | -0.09 | 7.00 | 135.00 |
Retained earnings | 1 979.71 | 3 020.38 | 3 472.90 | 3 258.64 | 3 710.26 |
Profit of the financial year | 1 026.68 | 565.43 | -97.17 | 803.63 | 479.12 |
Shareholders equity total | 3 169.38 | 3 632.90 | 3 425.64 | 4 119.27 | 4 374.38 |
Provisions | 6.60 | 5.50 | 3.30 | 2.20 | |
Non-current liabilities total | |||||
Current trade creditors | 9.50 | 9.70 | 10.59 | 13.50 | 13.50 |
Current owed to participating | 54.62 | 79.65 | 103.65 | 44.50 | 48.87 |
Short-term deferred tax liabilities | 206.55 | 66.20 | 83.37 | ||
Other non-interest bearing current liabilities | 100.58 | 155.27 | 171.28 | 178.74 | 81.00 |
Current liabilities total | 371.25 | 310.83 | 285.52 | 320.11 | 143.36 |
Balance sheet total (liabilities) | 3 547.23 | 3 949.22 | 3 711.16 | 4 442.68 | 4 519.94 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.